Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China

被引:1
|
作者
Lin, Ziwei [1 ]
Si, Si [1 ]
Liu, Jia [2 ]
Zhu, Hao [1 ]
Xu, Jiawei [1 ]
Artime, Esther [3 ]
Khare, Swarna [4 ]
Higgins, Victoria [5 ]
Leith, Andrea [5 ]
Qu, Shen [2 ,6 ]
机构
[1] Eli Lilly & Co, Suzhou, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Endocrinol & Metab Ctr, Sch Med, Shanghai, Peoples R China
[3] Eli Lilly & Co, Alcobendas, Spain
[4] Eli Lilly & Co, Bracknell, England
[5] Adelphi Real World, Bollington, England
[6] SinoUnited Hlth, Endocrinol Metab & Thyroid Ctr, Shanghai, Peoples R China
来源
关键词
China; dietary intervention; obesity therapy; real-world evidence; weight control; OBESITY; OVERWEIGHT;
D O I
10.3389/fendo.2024.1470394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To describe weight management and perceptions in China.Materials and methods Data were from the Adelphi Real World Obesity Disease Specific Programme (TM), a cross-sectional survey between April and July 2022 of physicians managing people with obesity or overweight (PwO) and PwO in real-world clinical practice in China. At data collection, eligible PwO were aged >= 18 years, under weight management and/or had a body mass index (BMI) >= 28 kg/m2.Results In total, 100 physicians and 801 PwO were enrolled. More than two thirds of PwO (70.7%; 531/751) were not diagnosed with obesity until a BMI >= 30 kg/m2. Most PwO (78%; 625/801) were on treatment for at least one obesity-related complication (ORC). Physicians commonly initiated weight loss discussions with PwO who already had an ORC (48.0%; 48/100). According to physicians and PwO, the mean target BMI was set at 25.8 kg/m2 and 24.3 kg/m2, and the mean target percentage weight loss was 19.6% and 23.7%, respectively. Over a median 6.4 months of weight management, the mean percentage weight loss was 4.1%. Few PwO achieved the weight loss target set by their physician (9.9%; 69/695) or themselves (2.0%; 14/696). Most physicians and PwO were unsatisfied with the current weight loss (92.3% [739/801] and 82.0% [650/793], respectively).Conclusions These findings suggest that earlier intervention may be needed to address obesity as a disease. Most physicians and PwO recognized the importance of normal weight, but few PwO achieved weight loss targets, which may suggest an unmet need for improved weight management.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Weight loss and treatment patterns in a real-world population of adults receiving liraglutide 3.0 mg for weight management in routine clinical practice in Switzerland (ADDRESS study)
    Schultes, Bernd
    Timper, Katharina
    Cavadini, Gionata
    Ruh, Josefine
    Gerber, Philipp A.
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 1023 - 1032
  • [2] Real-world weight loss with diabetes medications: But is it actually real?
    Elmes, Abigail T.
    Jarrett, Jennie B.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 27 - 27
  • [3] THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE
    Shibuya, Kelly
    Ali, Khazvla F.
    Ji, Xinge
    Milinoivh, Alex
    Bauman, Janine
    Kattan, Michael W.
    Pantalone, Kevin M.
    Burguera, Bartolome
    ENDOCRINE PRACTICE, 2019, 25 (10) : 1022 - 1028
  • [4] Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
    Wharton, Sean
    Liu, Aiden
    Pakseresht, Arash
    Nortoft, Emil
    Haase, Christiane L.
    Mancini, Johanna
    Power, G. Sarah
    Vanderlelie, Sarah
    Christensen, Rebecca A. G.
    OBESITY, 2019, 27 (06) : 917 - 924
  • [5] REAL-WORLD CLINICAL EFFECTIVENESS OF LIRAGLUTIDE 3.0 MG FOR WEIGHT MANAGEMENT IN CANADA
    Wharton, S.
    Liu, A.
    Pakseresht, A.
    Nortoft, E.
    Haase, C. L.
    Mancini, J.
    Power, G. S.
    VanderLelie, S.
    Christensen, R. A.
    VALUE IN HEALTH, 2018, 21 : S246 - S246
  • [6] A Real-World Study of the Effectiveness and Safety of Semaglutide for Weight Loss
    Tzoulis, Ploutarchos
    Batavanis, Michael
    Baldeweg, Stephanie
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [7] Association between a national behavioral weight management program and real-world weight change
    Hung, Anna
    Pura, John A.
    Stechuchak, Karen M.
    Dennis, Paul A.
    Maciejewski, Matthew L.
    Smith, Valerie A.
    V. Blalock, Dan
    Hoerster, Katherine
    Raffa, Susan D.
    Wong, Edwin
    OBESITY RESEARCH & CLINICAL PRACTICE, 2024, 18 (03) : 201 - 208
  • [8] Real-World Effectiveness of an Oral Superabsorbent Hydrogel for Weight Management
    Bialonczyk, Damian
    Zhou, Megan S.
    Broffman, Lauren
    Doron, Tzvi Y.
    Bowles, Jennifer
    Chiquette, Elaine
    DIABETES, 2023, 72
  • [9] Correlates of patient contact in a real-world weight management program
    Keith, Nicole R.
    Clark, Daniel O.
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S53 - S53
  • [10] Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes
    Del Prete, Michela
    Gavazzi, Lidia
    Disoteo, Olga Eugenia
    Vignati, Federico
    Di Sacco, Gianleone
    Muratori, Fabrizio
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2025, 30 (01)